Kamada (KMDA) Competitors

IDEAYA Biosciences (NASDAQ:IDYA) and Kamada (NASDAQ:KMDA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, community ranking, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

Do institutionals & insiders have more ownership in IDYA or KMDA?

98.3% of IDEAYA Biosciences shares are held by institutional investors. Comparatively, 20.4% of Kamada shares are held by institutional investors. 3.5% of IDEAYA Biosciences shares are held by insiders. Comparatively, 36.1% of Kamada shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has better earnings and valuation, IDYA or KMDA?

Kamada has higher revenue and earnings than IDEAYA Biosciences. IDEAYA Biosciences is trading at a lower price-to-earnings ratio than Kamada, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEAYA Biosciences	$7M	185.00	-$274.48M	-$3.30	-4.48
Kamada	$160.95M	2.13	$8.28M	$0.26	22.94

Does the MarketBeat Community favor IDYA or KMDA?

Kamada received 184 more outperform votes than IDEAYA Biosciences when rated by MarketBeat users. However, 71.72% of users gave IDEAYA Biosciences an outperform vote while only 66.26% of users gave Kamada an outperform vote.

Company	Underperform	Outperform
IDEAYA Biosciences	Outperform Votes 142 71.72%	Underperform Votes 56 28.28%
Kamada	Outperform Votes 326 66.26%	Underperform Votes 166 33.74%

Does the media prefer IDYA or KMDA?

In the previous week, IDEAYA Biosciences had 9 more articles in the media than Kamada. MarketBeat recorded 10 mentions for IDEAYA Biosciences and 1 mentions for Kamada. IDEAYA Biosciences' average media sentiment score of 0.65 beat Kamada's score of 0.65 indicating that IDEAYA Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEAYA Biosciences	2 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Kamada	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, IDYA or KMDA?

IDEAYA Biosciences has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500. Comparatively, Kamada has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500.

Is IDYA or KMDA more profitable?

Kamada has a net margin of 9.92% compared to IDEAYA Biosciences' net margin of 0.00%. Kamada's return on equity of 6.30% beat IDEAYA Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEAYA Biosciences	N/A	-26.74%	-25.54%
Kamada	9.92%	6.30%	4.49%

Do analysts prefer IDYA or KMDA?

IDEAYA Biosciences presently has a consensus price target of $53.58, indicating a potential upside of 262.20%. Kamada has a consensus price target of $14.67, indicating a potential upside of 145.88%. Given IDEAYA Biosciences' higher possible upside, research analysts clearly believe IDEAYA Biosciences is more favorable than Kamada.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEAYA Biosciences	0 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.93
Kamada	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Kamada beats IDEAYA Biosciences on 11 of the 19 factors compared between the two stocks.